Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 20439 [2019-09525]

Download as PDF Federal Register / Vol. 84, No. 90 / Thursday, May 9, 2019 / Notices the teleconference should contact Ms. Jamerson using the contact information below or may register for the GoToWebinar for the June 10, 2019, meeting at https:// attendee.gotowebinar.com/register/ 8147066000509193473. Contact Information: Kellee Jamerson, email: Kellee.Jamerson@nrc.gov, telephone: (301) 415–7408. to the public comments for NUREG– 1556, Volume 13, Revision 2 are available in ADAMS under Accession No. ML18305B303. III. Congressional Review Act This NUREG volume is a rule as defined in the Congressional Review Act (5 U.S.C. 801–808). However, the Office of Management and Budget has not found this NUREG revision to be a major rule as defined in the Congressional Review Act. Conduct of the Meeting Dated at Rockville, Maryland, this 2nd day of May 2019. For the Nuclear Regulatory Commission. Andrea L. Kock, Director, Division of Materials Safety, Security, State and Tribal Programs, Office of Nuclear Material Safety and Safeguards. [FR Doc. 2019–09485 Filed 5–8–19; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on June 10, 2019, to discuss: (1) The revisions to the ACMUI bylaws and (2) the draft report of the ACMUI Regulatory Guide 8.39 Subcommittee. This report will include the subcommittee’s comments and recommendations on Phase 1 of the revisions to Regulatory Guide 8.39, ‘‘Release of Patients Administered Radioactive Material.’’ A phased approach is being conducted by the NRC staff to comprehensively update Regulatory Guide 8.39. Phase 1 of the revision provides licensees with more detailed instructions to patients before and after they have been administered radioactive material than what is currently provided in Regulatory Guide 8.39. Meeting information, including a copy of the agenda and handouts, will be available at http://www.nrc.gov/ reading-rm/doc-collections/acmui/ meetings/2019.html. The agenda and handouts may also be obtained by contacting Ms. Kellee Jamerson using the information below. DATES: The teleconference meeting will be held on Monday, June 10, 2019, 2:00 p.m. to 4:00 p.m. Eastern Time. Public Participation: Any member of the public who wishes to participate in jbell on DSK3GLQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:39 May 08, 2019 Jkt 247001 Dr. Christopher Palestro, ACMUI Chairman, will preside over the meeting. Dr. Palestro will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson at the contact information listed above. All submittals must be received by June 4, 2019, three business days prior to the June 10, 2019, meeting, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website http://www.nrc.gov/reading-rm/ doc-collections/acmui/meetings/ 2019.html on or about July 23, 2019. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in 10 CFR part 7. Dated: May 6, 2019. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2019–09525 Filed 5–8–19; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2019–0103] Information Collection: Criteria and Procedures for Determining Eligibility for Access to or Control Over Special Nuclear Material Nuclear Regulatory Commission. ACTION: Renewal of existing information collection; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) invites public SUMMARY: PO 00000 Frm 00118 Fmt 4703 Sfmt 4703 20439 comment on the renewal of Office of Management and Budget (OMB) approval for an existing collection of information. The information collection is entitled, ‘‘Criteria and Procedures for Determining Eligibility for Access to or Control Over Special Nuclear Material.’’ DATES: Submit comments by July 8, 2019. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received on or before this date. ADDRESSES: You may submit comments by any of the following methods: • Federal Rulemaking website: Go to http://www.regulations.gov and search for Docket ID NRC–2019–0103. Address questions about NRC dockets to Jennifer Borges; telephone: 301–287–9127; email: Jennifer.Borges@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: David Cullison, Office of the Chief Information Officer, Mail Stop: T6–A10M, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415– 2084; email: Infocollects.Resource@ nrc.gov. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2019– 0103 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal Rulemaking website: Go to http://www.regulations.gov and search for Docket ID NRC–2019–0103. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Document collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, contact the NRC’s Public Document Room (PDR) E:\FR\FM\09MYN1.SGM 09MYN1

Agencies

[Federal Register Volume 84, Number 90 (Thursday, May 9, 2019)]
[Notices]
[Page 20439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09525]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on June 10, 2019, to discuss: (1) The revisions to the 
ACMUI bylaws and (2) the draft report of the ACMUI Regulatory Guide 
8.39 Subcommittee. This report will include the subcommittee's comments 
and recommendations on Phase 1 of the revisions to Regulatory Guide 
8.39, ``Release of Patients Administered Radioactive Material.'' A 
phased approach is being conducted by the NRC staff to comprehensively 
update Regulatory Guide 8.39. Phase 1 of the revision provides 
licensees with more detailed instructions to patients before and after 
they have been administered radioactive material than what is currently 
provided in Regulatory Guide 8.39. Meeting information, including a 
copy of the agenda and handouts, will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html. The 
agenda and handouts may also be obtained by contacting Ms. Kellee 
Jamerson using the information below.

DATES: The teleconference meeting will be held on Monday, June 10, 
2019, 2:00 p.m. to 4:00 p.m. Eastern Time.
    Public Participation: Any member of the public who wishes to 
participate in the teleconference should contact Ms. Jamerson using the 
contact information below or may register for the GoToWebinar for the 
June 10, 2019, meeting at https://attendee.gotowebinar.com/register/8147066000509193473.
    Contact Information: Kellee Jamerson, email: 
[email protected], telephone: (301) 415-7408.

Conduct of the Meeting

    Dr. Christopher Palestro, ACMUI Chairman, will preside over the 
meeting. Dr. Palestro will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson at the contact information listed 
above. All submittals must be received by June 4, 2019, three business 
days prior to the June 10, 2019, meeting, and must pertain to the topic 
on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html on or about July 23, 2019.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated: May 6, 2019.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-09525 Filed 5-8-19; 8:45 am]
BILLING CODE 7590-01-P